MA48852A

Aav-mediated expression of anti-influenza antibodies and methods of use thereof

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

15 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims8

Priority claims
DocumentOfficeKindDate
201562161192United States of AmericaP
201562161192United States of AmericaP
201662323348United States of AmericaP
201662323348United States of AmericaP
201562161192P
201662323348
US201562161192P
US201662323348P

Members15

Family members, oldest first
DocumentOfficeKind
CA2985081A1CanadaA1
WO2016200543A2World Intellectual Property Organization (WIPO)A2
WO2016200543A9World Intellectual Property Organization (WIPO)A9
WO2016200543A3World Intellectual Property Organization (WIPO)A3
WO2016200543A8World Intellectual Property Organization (WIPO)A8
AU2016275909A1AustraliaA1
EP3307310A2European Patent Office (EPO)A2
EA201792500A1Eurasian Patent Organization (EAPO)A1
US2018155412A1United States of AmericaA1
CN108135994AChinaA
MA48852AThis recordMoroccoA
CN108135994BChinaB
AU2022203342A1AustraliaA1
US11535665B2United States of AmericaB2
US2023331826A1United States of AmericaA1